Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Desensitization of the immune system through allergen exposure, also known as allergen immunotherapy, is a medical approach used to reduce or eliminate allergic reactions by gradually training the immune system to tolerate specific allergens. This process involves controlled and repeated exposure to increasing doses of an allergen, either via injections or sublingual administration. The therapy aims to induce tolerance by modulating immune cell populations and antibody production, leading to long-term relief from allergy symptoms.
Gradual exposure to allergen induces regulatory T cells, shifts antibody production from IgE to IgG4/IgA, and reduces mast cell and basophil activation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immune System (Desensitization via Allergen Exposure).